• L’universitaire et homme politique Américano-Gabonais Daniel MENGARA sera l’invité d’Afrique 2050 (États-Unis) et Radio PDCI-RDA (Côte-d’Ivoire) ce samedi 11 juillet pour une émission spéciale.
  • AFRICOM HOMESTEAD EXEMPTION A PHILADELPHIE IMMIGRES, REFUGIES AFRICAINS ET HAITIENS A PHILADELPHIE, CE PROGRAMME VOUS CONCERNE
  • EMISSION SCA : LE COVID 19 EST UNE REALITE EN CI – DR MELANIE USHER EST NOTRE INVITEE – JEU 02 JUILLET 2020 A 19H GMT ET 15H (NY)
  • L’HONORABLE IBRAHIMA ABE SYLLA PRESIDENT DE LA NGR-GUINEE EST NOTRE INVITE VEN 26 JUIN 2020 A 19H – SERA T’IL CANDIDAT A L’ELECTION PRESIDENTIELLE D’OCTOBRE 2020???
  • Watch Democracy Grow Webinar Series on The New World Order ushered in by Covid-19
  • Chronologie de la Côte d’Ivoire (1958-2011)
  • AHMED TIDJANE SYLLA (UFR GUINÉE) EST L’INVITÉ DE JACQUES ROGER VEN 10 JUILLET 2020 A PARTIR DE 23H GMT – 19H NEW YORK
  • Washington, DC: Registre de condoléances en ligne et à l’Ambassade pour Amadou Gon
  • L’honorable KOUADIO Konan Bertin (KKB) est l’invité de Jacques-Roger de AFRIQUE2050 ce jeudi 9 Juillet 2020 – 00H GMT – 20H NYork
  • Côte d’Ivoire : le premier ministre et candidat à la présidentielle Amadou Gon Coulibaly est mort
  • COMMUNIQUE : DECES SURVENU LE 15 JUIN 2020 LE LIKOUA GNAORE
  • EMISSION : HANDICAP ET PERSPECTIVES DE DEVELOPPEMENT INCLUSIF – MER 08 JUILLET 2020 A 17H00 NEW YORK – 21H GMT
  • POLITIQUE : L’ombre d’Houphouët-Boigny sur la politique ivoirienne, à six mois de la présidentielle
  • M. Bernard HOUDIN (Paris) et Dr Éric ÉDI (Philadelphie) sont les invités d’Afrique 2050 (États-Unis) et Radio PDCI-RDA ce samedi 4 juillet pour une émission spéciale.
  • EMISSION : HANDICAP ET PERSPECTIVES DE DEVELOPPEMENT INCLUSIF – SOLIDARITE AUX VICTIMES DES CATASTROPHES NATURELLES
  • TECHNOLOGIE : Amazon rachète à la Sénégalaise Aicha Sarr sa startup Zoox à 1 milliard US Dollar
  • Facebook cède au boycott des annonceurs et à la campagne contre la diffusion de contenus litigieux
  • GUINEE – DR FAYA MILLIMOUNO LEADER DU (BLOC LIBERAL) ACCUSE D’ETRE UN ENSEIGNANT FICTIF REPOND CE MAR 30 JUIN LUN 19 JUIN 2020 A 18H30 NEW YORK – 22H30 GMT
  • AFRIQUE – La suspension du service de la dette par le G20 aura finalement un faible impact sur l’Afrique
  • Economie Guinée : 141 millions $ de la Banque mondiale pour promouvoir l’autonomisation des femmes et lutter contre la COVID-19
  • M. IMHOTEP BRUNO MOUBAMBA, INVITÉ D’AFRIQUE 2050 (ETATS-UNIS)/ RADIO PDCI-RDA (COTE-D’IVOIRE)
  • COMMUNIQUE/ DIASPORA COTE D’IVOIRE : OPERATION D’ENROLEMENT DES ELECTEURS- PRESIDENTIELLE 2020
  • CORONAVIRUS: There is a cure’: California biotech company claims it’s discovered an antibody that can block ‘100%’ of coronavirus infections

    By in Actualités share share share share share share share share share share share share share share share share share share

    EXCLUSIVE — A California-based biopharmaceutical company claims to have discovered an antibody that could shield the human body from the coronavirus and flush it out of a person’s system within four days, Fox News has exclusively learned.

    Later Friday, Sorrento Therapeutics will announce their discovery of the STI-1499 antibody, which the San Diego company said can provide “100% inhibition” of COVID-19, adding that a treatment could be available months before a vaccine hits the market.

    “We want to emphasize there is a cure. There is a solution that works 100 percent,” Dr. Henry Ji, founder and CEO of Sorrento Therapeutics, told Fox News. “If we have the neutralizing antibody in your body, you don’t need the social distancing. You can open up a society without fear.”

    “This puts its arms around the virus. It wraps around the virus and moves them out of the body.”— Dr. Henry Ji, CEO and founder, Sorrento Therapeutics

    The health care and pharmaceutical industries have been scrambling to develop viable vaccines and antibody treatments as the number of COVID-19-related deaths is expected to hit 100,000 by June 1.

    Many medical researchers are scrambling to find antibodies, optimistic that they could provide a remedy or preventative care in less time than it would take to develop a vaccine. Antibody treatments have been used for the past 100 years as a means to stave off infections, but their effectiveness has had mixed results. Finding a successful antibody or convalescent plasma treatment for COVID-19 could present challenges.

    Multiple companies and universities around the world have been exploring the use of antibodies to treat coronavirus. 

    Encouragingly, the antibody discovered by Sorrento belongs to a class called ‘neutralizing,’ or binding antibodies.

    They fully and specifically bind to the part of the virus that fits like a lock in a key with parts of human cells.

    According to Dr Derek Lowe, an organic chemist who writes for Science Translational Medicine, these both block the virus and sound the alarm to the rest of the immune system to mount a response, too.

    These are preferable to other types of antibodies which don’t entirely block the virus’s effects, and could accidentally make it easier for it to enter human cells.  

    Dr Lowe notes that neutralizing antibodies, in general, also have the potential to act like ‘temporary vaccines,’ preventing coronavirus infection in people who haven’t already contracted it.  

    Tags:
    Recommended posts